viracept 250mg tablets
roche products ltd - nelfinavir mesilate - tablet - 250mg
viracept 50mgg oral powder
roche products ltd - nelfinavir mesilate - powder - 50mg/1gram
viracept 625mg tablets
imported (united states - nelfinavir mesilate - tablet - 625mg
avifix tablet
beximco pharmaceuticals ltd. - nelfinavir - tablet - 250 mg
nelidel tablet
delta pharma limited - nelfinavir - tablet - 250 mg
nefivir tablet
drug international ltd. - nelfinavir - tablet - 250 mg
nelvir tablet
square pharmaceuticals plc, pabna - nelfinavir - tablet - 250 mg
sedacid 10 mg gastro-resistant tablets
pinewood laboratories ltd, - omeprazole ph. eur. - tablets gastro-resistant - 10 milligram
sedacid 20 mg gastro-resistant tablets
pinewood laboratories ltd, - omeprazole ph. eur. - tablets gastro-resistant - 20 milligram
glivec 100 mg
novartis israel ltd - imatinib as mesylate - film coated tablets - imatinib as mesylate 100 mg - imatinib - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist).glivec is also indicated for the treament of : * adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy.* adult patients with relapsed or refractory ph + all as monotherapy.* adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. * adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr (platelet - derived growth factor receptor ) gene re- arrangements. * adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) who have the fip1l1- pdgfralfa fusion kinase (mutational analysis or fish demonstration fo chic2 allele deletion) and for patients with hes and/or cel who are fip1l1-pdgfr alfa fusion kinase negative. * adult patients with aggressive systemic mastocytosis (asm) without the d816v c-kit mutation.* adjuvant treatment of adult patients following complete gross resection of kit (cd117) positive gist.